✦ LIBER ✦

362 First in human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients (p) with antitumor activity in BRCA-deficient and sporadic ovarian cancers

✍ Scribed by R.M. Wenham; S.K. Sandhu; G. Wilding; L. Sun; C. Toniatti; M. Stroh; C. Carpenter; J. de-Bono; R. Baird; W.R. Schelman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First in human trial of the poly(ADP)-ri

✍ R. Wenham; G. Wilding; R. Baird; L. Sun; C. Toniatti; M. Stroh; C. Carpenter; J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

352 Final Results of the First in Man Tr

✍ Sandhu, S.K.; Wilding, G.; Schelman, W.R.; Omlin, A.; Kreischer, N.; Carpenter, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

The poly(ADP-ribose) polymerase inhibito

✍ Sandhu, Shahneen K; Schelman, William R; Wilding, George; Moreno, Victor; Baird, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 435 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ M William Audeh; James Carmichael; Richard T Penson; Michael Friedlander; Bethan 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 268 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ Andrew Tutt; Mark Robson; Judy E Garber; Susan M Domchek; M William Audeh; Jeffr 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 594 KB

Oral poly(ADP-ribose) polymerase inhibit

✍ Gelmon, K.A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 107 KB